Eben Tessari Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

Eben Tessari is CHIEF OPERATING OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 95,975 shares of KNSA, which is worth approximately $1.98 Million. The most recent transaction as insider was on Dec 16, 2024, when has been sold 23,017 shares (Class A Ordinary Share) at a price of $20.44 per share, resulting in proceeds of $470,467. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 96K

17.95% 3M change

22.21% 12M change

Total Value Held $1.98 Million

Eben Tessari Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 16 2024	SELL Open market or private sale	$470,467 $20.44 p/Share	23,017 Reduced 19.34%	95,975 Class A Ordinary Share
Dec 16 2024	BUY Exercise of conversion of derivative security	$25,467 $1.59 p/Share	16,017 Added 11.86%	118,992 Class A Ordinary Share
Nov 18 2024	SELL Open market or private sale	$357,680 $21.04 p/Share	17,000 Reduced 14.17%	102,975 Class A Ordinary Share
Nov 18 2024	BUY Exercise of conversion of derivative security	$15,900 $1.59 p/Share	10,000 Added 7.69%	119,975 Class A Ordinary Share
Oct 15 2024	SELL Open market or private sale	$456,790 $26.87 p/Share	17,000 Reduced 13.39%	109,975 Class A Ordinary Share
Oct 15 2024	BUY Exercise of conversion of derivative security	$15,900 $1.59 p/Share	10,000 Added 7.3%	126,975 Class A Ordinary Share
Sep 23 2024	SELL Open market or private sale	$437,325 $24.99 p/Share	17,500 Reduced 13.01%	116,975 Class A Ordinary Share
Sep 23 2024	BUY Exercise of conversion of derivative security	$15,900 $1.59 p/Share	10,000 Added 6.92%	134,475 Class A Ordinary Share
Sep 02 2024	SELL Payment of exercise price or tax liability	$15,428 $26.74 p/Share	577 Reduced 0.46%	124,475 Class A Ordinary Share
Sep 02 2024	BUY Exercise of conversion of derivative security	-	1,964 Added 1.55%	125,052 Class A Ordinary Share
Sep 01 2024	SELL Payment of exercise price or tax liability	$35,350 $26.74 p/Share	1,322 Reduced 1.06%	123,088 Class A Ordinary Share
Sep 01 2024	BUY Exercise of conversion of derivative security	-	4,499 Added 3.49%	124,410 Class A Ordinary Share
Aug 27 2024	SELL Open market or private sale	$470,925 $26.91 p/Share	17,500 Reduced 12.74%	119,911 Class A Ordinary Share
Aug 27 2024	BUY Exercise of conversion of derivative security	$15,900 $1.59 p/Share	10,000 Added 6.78%	137,411 Class A Ordinary Share
Apr 08 2024	SELL Payment of exercise price or tax liability	$14,337 $17.9 p/Share	801 Reduced 0.63%	126,024 Class A Common Share
Apr 08 2024	BUY Exercise of conversion of derivative security	-	2,726 Added 2.1%	126,825 Class A Common Share
Apr 01 2024	SELL Payment of exercise price or tax liability	$10,263 $19.7 p/Share	521 Reduced 0.42%	124,099 Class A Common Share
Apr 01 2024	BUY Exercise of conversion of derivative security	-	1,773 Added 1.4%	124,620 Class A Common Share
Mar 01 2024	SELL Open market or private sale	$26,193 $22.03 p/Share	1,189 Reduced 0.96%	122,847 Class A Common Share
Mar 01 2024	BUY Exercise of conversion of derivative security	$1,043 $1.59 p/Share	656 Added 0.53%	124,036 Class A Common Share
Sep 02 2023	SELL Payment of exercise price or tax liability	$10,247 $17.76 p/Share	577 Reduced 0.47%	123,380 Class A Common Share
Sep 02 2023	BUY Exercise of conversion of derivative security	-	1,964 Added 1.56%	123,957 Class A Common Share
Sep 01 2023	SELL Payment of exercise price or tax liability	$14,225 $17.76 p/Share	801 Reduced 0.65%	121,993 Class A Common Share
Sep 01 2023	BUY Exercise of conversion of derivative security	-	2,727 Added 2.17%	122,794 Class A Common Share
Apr 10 2023	SELL Payment of exercise price or tax liability	$8,578 $10.71 p/Share	801 Reduced 0.66%	120,067 Class A Common Share

Eben Tessari

CHIEF OPERATING OFFICER

Hamilton, D0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account